Lexaria Bioscience Corp. (NASDAQ:LEXXW) Short Interest Update

Lexaria Bioscience Corp. (NASDAQ:LEXXW) was the target of a significant growth in short interest in March. As of March 15th, there was short interest totalling 2,400 shares, a growth of 20.0% from the February 28th total of 2,000 shares. Based on an average daily trading volume, of 10,800 shares, the days-to-cover ratio is presently 0.2 days.

Lexaria Bioscience Price Performance

Shares of LEXXW traded down $0.09 during midday trading on Thursday, hitting $0.21. The company had a trading volume of 300 shares, compared to its average volume of 12,279. The company’s 50 day moving average price is $0.31 and its 200 day moving average price is $0.62. Lexaria Bioscience has a 52 week low of $0.16 and a 52 week high of $2.00.

About Lexaria Bioscience

Lexaria Bioscience Corp. operates as a biotechnology company. It develops and out-licenses its patented drug delivery technology, DehydraTECH, which combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods.